2472
T. USUI et al.
pp. 421–423 (1963).
oxidative 3DG formation, oxidative GLUCO formation,
GLA formation, and other pathways. It is suggested that
ꢀ-dicarbonyl compounds are formed in hyperglycemia
from diabetes, and by the infusion of glucose-containing
medicines such as peritoneal dialysis solution. Carbon-
yls might cause the progression of metabolic diseases.
8) Kato, H., Chuyen, N. V., Shinoda, T., Seiya, F., and
Hayase, F., Metabolism of 3-deoxyglucosone, an inter-
mediate compound in the Maillard reaction, adminis-
tered orally or intravenously to rats. Biochem. Biophys.
Acta, 1035, 71–76 (1990).
9) Usui, T., Yoshino, M., Watanabe, H., and Hayase, F.,
Determination of glyceraldehyde formed in the glucose
degradation and glycation. Biosci. Biotechnol. Biochem.,
71, 2162–2168 (2007).
References
10) Shinoda, T., Hayase, F., and Kato, H., Suppression of
cell-cycle progression during the S phase of rat fibro-
blasts by 3-deoxyglucosone, a Maillard reaction inter-
mediate. Biosci. Biotechnol. Biochem., 58, 2215–2219
(1994).
11) Okado, A., Kawasaki, Y., Hasuike, Y., Takahashi, M.,
Teshima, T., Fujii, J., and Taniguchi, N., Induction of
apoptotic cell death by methylglyoxal and 3-deoxyglu-
cosone in macrophage-derived cell lines. Biochem.
Biophys. Res. Commun., 225, 219–224 (1996).
1) Kato, H., and Hayase, F., Post-translational modification
of proteins by advanced amino-carbonyl reaction. In
‘‘The Post-Translational Modification of Proteins,’’ eds.
Tuboi, S., Taniguchi, N., and Katunuma, N., Japan
Scientific Societies Press and CRC Press, Tokyo,
pp. 237–251 (1992).
2) Hayase, F., Recent development of 3-deoxyosone related
Maillard reaction products. Food Sci. Technol. Res., 6,
79–86 (2000).
3) Niwa, T., 3-Deoxyglucosone: metabolism, analysis,
biological activity, and clinical implication. J. Chroma-
togr. B, 731, 23–36 (1999).
4) Knecht, K. J., Feather, M. S., and Baynes, J. W.,
Detection of 3-deoxyfructose and 3-deoxyglucosone in
human urine and plasma: evidence intermediate stage of
the Maillard reaction in vivo. Arch. Biochem. Biophys.,
294, 130–137 (1992).
5) Yamada, H., Miyata, S., Igaki, N., Yatabe, N., Miyauchi,
Y., Ohara, T., Sakai, M., Shoda, H., Oimomi, M., and
Kasuga, M., Increase in 3-deoxyglucosone levels in
diabetic rat plasma: specific in vivo determination of
intermediate in advanced Maillard reaction. J. Biol.
Chem., 269, 20275–20280 (1994).
6) Niwa, T., Katsuzaki, T., Miyazaki, S., Miyazaki, T.,
Ishizaki, Y., Hayase, F., Takemichi, N., and Takei, Y.,
Immunohistochemical detection of imidazolone, a novel
advanced glycation end product, in kidneys and aortas of
diabetic patients. J. Clin. Invest., 99, 1272–1280 (1997).
7) Bayne, S., Aldosuloses (osones) from phenylosazones.
In ‘‘Methods Carbohydrate Chemistry II,’’ eds. Whistler,
R. L., and Wolfrom, M. L., Academic Press, New York,
12) Kikuchi, S., Shinpo, K., Moriwaka, F., Makita, Z.,
Miyata, T., and Tashiro, K., Neurotoxicity of methyl-
glyoxal and 3-deoxyglucosone on cultured cortical
neurons: synergism between glycation and oxidative
stress, possibly involved in neurodegenerative diseases.
J. Neurosci. Res., 57, 280–289 (1999).
13) Linden, T., Cohen, A., Deppisch, R., Kjellstrand, P.,
and Wieslander, A., 3,4-Dideoxyglucosone-3-ene (3,4-
DGE): a cytotoxic glucose degradation product in fluids
for peritoneal dialysis. Kidney Int., 62, 697–703 (2002).
14) Janzowski, C., Glaab, V., Samimi, E., Schlatter, J., and
Eisenbrand, G., 5-Hydroxymethylfurfural: assessment of
mutagenicity, DNA-damaging potential and reactivity
towards cellular glutathione. Food Chem. Tox., 38, 801–
809 (2000).
15) Inagi, R., Miyata, T., Yamamoto, T., Suzuki, D.,
Urakami, K., Saito, A., Strihou, C. Y., and Kurokawa,
K., Glucose degradation product methylglyoxal enhan-
ces the production of vascular endothelial growth factor
in peritoneal cells: role in the functional and morpho-
logical alterations of peritoneal membranes in peritoneal
dialysis. FEBS Lett., 463, 260–264 (1999).